To further verify the influence of tumor-derived IL-1β and IL-23 on Vγ4+ and Vγ6+ cells in vivo, we treated KB1P mice bearing end-stage tumors with blocking antibodies against the cytokines. Here, IL1B is linked to neoplasm.